Research
Immuno-oncology
Our latest immuno-assay platforms and analytical tools enable prciese evaluation of immune responses and mechanisms of action behind potential therapeutic candidates.
Our expertise in immuno-oncology extends beyond traditional approaches, incorporating epigenetics, targeted proteomics and bioinformatics to identify novel targets and biomarkers, thereby improving cancer therapy and patient outcomes.
